-
Correction to Lancet Child Adolesc Health 2025; 9: 213–15 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-17
-
Correction to Lancet Child Adolesc Health 2025; 9: 292–94 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15
-
Correction to Lancet Child Adolesc Health 2025; 9: 89–99 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15
-
Management of severe acute pulmonary haemorrhage in children Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Alexander I Gipsman MD, Lauren M C Grant MD, Prof Joseph C Piccione DO, Nadir Yehya MD, Char Witmer MD, Lisa R Young MD, Antoinette Wannes Daou MD, Abhay Srinivasan MD, Pelton A Phinizy MD
Pulmonary haemorrhage is a potentially life-threatening condition with a variety of causes. Quality clinical trials are insufficient in children, restricting the evidence base to observational data and adult studies. The overall management strategy should address control of symptomatic bleeding, identification of the bleeding source, and treatment of the underlying cause. Flexible bronchoscopy is an
-
Early childhood height, weight, and BMI development in children with monogenic obesity: a European multicentre, retrospective, observational study Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Stefanie Zorn PhD, Cornelis Jan de Groot PhD, Stephanie Brandt-Heunemann PhD, Julia von Schnurbein PhD, Ozair Abawi PhD, Rebecca Bounds PhD, Lisa Ruck MD, Blanca Guijo MD, Gabriel Á Martos-Moreno PhD, Clarisse Nicaise MD, Sophie Courbage MD, Margit Klehr-Martinelli PhD, Prof Reiner Siebert MD, Prof Béatrice Dubern PhD, Prof Christine Poitou PhD, Prof Karine Clément PhD, Prof Jesús Argente PhD, Prof
Monogenic defects in the leptin-melanocortin pathway are associated with hyperphagia and severe, early-onset obesity. Early childhood growth patterns in height, weight, and BMI, might serve as phenotypic markers for specific genetic disorders; however, reliable data are scarce. This study aimed to evaluate the natural history of height, weight, and BMI in early childhood in a large European group of
-
Centring the child in complex decision making Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Giuliana C Antolovich, Ingrid Sutherland, Zoe McCallum, Monica S Cooper
-
Efficacy of interventions for the treatment of irritable bowel syndrome, functional abdominal pain—not otherwise specified, and abdominal migraine in children: a systematic review and network meta-analysis Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Vasiliki Sinopoulou RD, Jip Groen MD, Prof Morris Gordon PhD, Ed Mougey PhD, James P Franciosi MD, Tim G J de Meij PhD, Merit M Tabbers PhD, Prof Marc A Benninga PhD
Many treatments for abdominal pain-related disorders of gut–brain interaction (AP-DGBI) in children have been studied. We aimed to assess the efficacy and safety of all known treatment options for paediatric AP-DGBI.
-
BMI profiling for monogenic obesity testing Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Vidhu V Thaker, Dympna Gallagher
-
Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Martina Penazzato PhD, Asma Hafiz MSc, Sébastien Morin PhD, Farihah Malik PhD, Bernadette Cappello MPH, Jennifer Cohn MD, Tim R Cressey PhD, Patricia Fassinou MD, Anthony J Garcia-Prats MD, Luann Hatane MPhil, Janice Soo Fern Lee MPharm, Tiziana Masini PhD, Atieno Ojoo MPH, Theodore Ruel MD, David Ruiz Villafranca PhD, Marie Valentin PharmD, John C Reeder PhD
Despite progress in reducing neonatal and child mortality, access to age-appropriate medicines remains inequitable, particularly in low-income and middle-income countries. The Global Accelerator for Paediatric Formulations (GAP-f), a WHO-hosted network established in 2020, addresses these gaps by uniting 33 partners to promote innovation and access to child-friendly formulations. Phase 2 (2022–24)
-
Efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with respiratory syncytial virus infection in China: findings from a phase 3 randomised trial with 24-month follow-up Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Han Zhang MD, Prof Wei Zhao PhD, Xiaoyan Zhang MD, Lei Zhang MD, Run Guo MD, Han Huang MD, Li Lin MD, Feng Liu MD, Haidan Chen MD, Fangfang Shen MD, Jinzhun Wu MD, Xiaowen Huang MD, Xiaoping Zhu PhD, Feng Li PhD, Gang Zou PhD, Jason Chien MD, Michael Humphries MD, Prof Quan Lu MD, Jim Z Wu PhD, Prof Shunying Zhao PhD, Prof Hanmin Liu PhD, Prof Xin Ni PhD, AIRFLO Study Group, Cilang Hu, Xueyun Lv, Lili
Respiratory syncytial virus (RSV) is a particularly dangerous infection in some populations, including very young infants. This study examined the efficacy and safety of ziresovir in hospitalised infants aged 6 months or younger with RSV infection.
-
Treatment for paediatric respiratory syncytial virus infection Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-15 Eric A F Simões
-
Navigating the complexities of adolescent health and social media. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-07 Megan A Moreno,Jenny Radesky,Nicole Owings-Fonner
-
Dismantling barriers and biases against adolescent mothers Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-04-06 The Lancet Child & Adolescent Health
-
Immunogenicity and safety of a measles and rubella-containing vaccine at age 6 and 9 months in Bangladesh: an open-label, randomised trial Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-31 Takudzwa S Sayi PhD, Umid M Sharapov, Zachary Matson MPH, Melissa M Coughlin PhD, Stephen N Crooke PhD, Qian An PhD, Jennifer K Knapp PhD, Asma Binte Aziz MBBS, Mohammad Yunus MSc CHDC, Warda Haque MSc, Sohel Rana MSc, Md Al Fazal Khan PhD, James P Alexander MD, Katrina Kretsinger, Paul A Rota PhD, Khalequ Zaman PhD, Abhijeet Anand MBBS
The first dose of measles–rubella (MR) vaccine is routinely administered to infants aged 9 months as part of a standard two-dose schedule. However, during large measles outbreaks and in other settings of increased circulation or increased risk, WHO recommends administering a supplementary dose at age 6 months to protect young infants. We aimed to assess the immunogenicity and safety of a first dose
-
Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-23 Bryan J Vonasek, Olivier Marcy, Jasmine Armour-Marshall, Martina Casenghi, Cécile Cazes, Mohammod Jobayer Chisti, Marc d’Elbée, Helena Huerga, Cathy Hewison, Christina L Lancioni, Patrick S Lungu, Eric D McCollum, Victor Musiime, Tisungane Mvalo, James A Seddon, Andrew P Steenhoff, Tania A Thomas, Marco Tovar, Anca Vasiliu, Anthony Garcia-Prats, Chishala Chabala
-
Correction to Lancet Child Adolesc Health 2025; 9: 10–14 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18
-
Correction to Lancet Child Adolesc Health 2025; 9: 9 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18
-
-
Dexamethasone for paediatric pneumococcal meningitis Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Simon Nadel
-
Adjunctive dexamethasone and 30-day all-cause death after hospital admission in paediatric pneumococcal meningitis: a propensity score analysis Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Anna Giolito MD, Corinne Levy MD, Emmanuelle Varon MD, Prof Robert Cohen MD, Sidonie Hanna MD, Zein Assad MD, Léa Lenglart MD, Stephane Bechet MSc, Stephane Bonacorsi MD PhD, Prof François Dubos MD PhD, Prof Elise Launay MD PhD, Morgane Pelleter MD, Alexis Rybak MD PhD, Prof Francois Angoulvant MD PhD, Michael Levy MD PhD, Prof Naïm Ouldali MD PhD, French Paediatric Meningitis Network, Véronique ABADIE
Pneumococcal meningitis is a leading cause of bacterial meningitis and the most deadly pneumococcal disease in children worldwide. There is a paucity of evidence concerning the benefit of dexamethasone to prevent death in paediatric pneumococcal meningitis. We aimed to compare the effect of early adjunctive therapy with dexamethasone versus no dexamethasone on death in children with pneumococcal meningitis
-
Healthy skin for children and young people with skin of colour starts with clinician knowledge and recognition: a narrative review Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Bernadette M Ricciardo MBBS FACD, Heather-Lynn Kessaris BSc MD, Prof Sarah Cherian MBBS PhD, Prof S Prasad Kumarasinghe MBBS FACD, Ingrid Amgarth-Duff PhD, Dasmesh Sron BCom MD, Prof Regina Oladokun MBBS FMCPaed, Artiene H Tatian MBBS FACD, Prof Asha C Bowen MBBS PhD
Skin conditions most frequently encountered in paediatric practice include infections, infestations, atopic dermatitis, and acne. Skin of colour refers to skin with increased melanin and darker pigmentation, and reflects global racial and ethnic diversity. Managing skin conditions in skin of colour requires health equity nuance, which is rarely explicitly taught. Awareness of the demographic factors
-
1-year follow-up of oral versus intravenous antibiotics in children and adolescents with uncomplicated bone and joint infections: a nationwide, randomised, controlled, non-inferiority trial in Denmark Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Allan Bybeck Nielsen, Mette Holm, Paul Blanche, Tobias Nygaard, Ulrikka Nygaard, Danish CHILD study group, Allan B Nielsen, Mette Holm, Morten S Lindhard, Jonathan P Glenth⊘j, Luise Borch, Ulla Hartling, Lisbeth S Schmidt, Maren J H Rytter, Annett H Rasmussen, Mads Damkjær, Grethe Lemvik, Jens J H Petersen, Mia J S⊘ndergaard, Jesper Thaarup, Kim Kristensen, Lise H Jensen, Lotte H Hansen, Marie C Lawaetz
-
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Hylke Waalewijn PhD, Mounier Almett MSc, Roeland E Wasmann PhD, Tim R Cressey PhD, Prof Philippa Easterbrook MPH, Peter Ehizibue Olumese MD, Prof Anneke C Hesseling PhD, Anthony J Garcia-Prats MD, Prof Joel Tarning PhD, Anna Turkova MRCPCH, Kerri Viney PhD, Elin M Svensson PhD, Angela Colbers PhD, Wilson M Were MMed, Prof Paolo Denti PhD, Martina Penazzato PhD, members of the expert panels, David M
Generally, dose recommendations for children are expressed as fixed dosing increments related to bodyweight, known as weight bands. The weight bands recommended in WHO treatment guidelines vary between diseases, leading to complexity and potential dosing errors when treating children for multiple diseases simultaneously. The introduction of a harmonised weight banding approach for orally administered
-
Will societal change improve mental health? Lessons from cohorts of adolescents in London and Tokyo Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Takahiro Nemoto, Takashi Uchino
-
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Prof Regino P Gonzalez-Peralta MD, Prof Jessica W Wen MD, Prof Winita Hardikar FRACP PhD, Prof Wikrom W Karnsakul MD, Prof Suzanne Whitworth MD, Prof Chuan-Hao Lin MD, Prof Giuseppe Indolfi MD PhD, Prof Philip Rosenthal MD, Prof William Balistreri MD, Prof Kathleen B Schwarz MD, Jonathan R Honegger MD, Xu Zhang PhD, Evguenia C Svarovskaia PhD, Vithika Suri MSc, Kathryn Kersey MSc, Prof Daniel H Leung
Direct-acting antiviral treatment is associated with high rates of sustained virological response and has a favourable safety profile in children aged 3–17 years with chronic hepatitis C virus (HCV) infection, but data describing the durability of sustained virological response and its effects on growth and sexual development are needed. This study aimed to assess the efficacy and long-term effects
-
Growth of children who are HIV-exposed but uninfected: a systematic review and meta-analysis Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Gabriel Loni Ekali PhD, Pascal Roland Enok Bonong PhD, Cyprien Kengne-Nde MSc, Julie Jesson PhD, Ceri Evans PhD, Prof Andrew J Prendergast DPhil, Valériane Leroy PhD
Pooled analyses summarising long-term growth outcomes in children who are HIV-exposed uninfected (HEU) compared with children who are HIV-unexposed (HU) are lacking. We aimed to summarise the existing literature on growth outcomes.
-
Trajectories of depressive symptoms among young people in London, UK, and Tokyo, Japan: a longitudinal cross-cohort study Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Gemma Knowles PhD, Daniel Stanyon MSc, Syudo Yamasaki PhD, Mitsuhiro Miyashita PhD, Charlotte Gayer-Anderson PhD, Kaori Endo PhD, Satoshi Usami PhD, Junko Niimura PhD, Naomi Nakajima PhD, Kaori Baba PhD, Thai-sha Richards, Jonas Kitisu, Adna Hashi, Karima Shyan Clement-Gbede, Niiokani Tettey, Samantha Davis MSc, Katie Lowis MSc, Verity Buckley MSc, Dario Moreno-Agostino PhD, Esther Putzgruber MSc,
Research suggests gender inequalities in adolescent mental health are context dependent and might be preventable through social and structural change. However, variations in the size of gender inequalities in mental health across diverse cultural contexts could be due to incomparable measurement. We aimed to compare a measurement of mental health among young people in Tokyo, Japan, and London, UK,
-
Ben Perks: we can end childhood trauma Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-18 Jules Morgan
-
Mpox among children in Africa Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-17 Kyeng Mercy, Christian Ngandu, Patrick Kabwe, Adaora Ejikeme, Cho Wazih, Moréniké Oluwátóyìn Foláyan, Nicaise Ndembi, Alain Ngashi Ngongo
-
America's children deserve a credible plan for better health Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-06 The Lancet Child & Adolescent Health
-
USAID funding freeze fails children globally Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-06 Vijay Shankar Balakrishnan
-
Correction to Lancet Child Adolesc Health 2025; 9: 184-93. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01
-
An international response to asking difficult FASD questions - Authors' reply. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Sabrina H Y Eliason,Anton R Miller,W Ben Gibbard,Gurpreet Salh,Nancy Lanphear
-
An international response to asking difficult FASD questions. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Jocelynn Cook,Elizabeth Elliott,Jessica Birch,Melissa Tremblay,Sarah Mattson
-
Correction to Lancet Child Adolesc Health 2025; 9: 89-99. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01
-
Trajectories of airflow limitation from childhood to early adulthood: an analysis of six population-based birth cohorts. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Anhar Ullah,Raquel Granell,Lesley Lowe,Sara Fontanella,Hasan Arshad,Clare S Murray,Steve Turner,John W Holloway,Angela Simpson,Graham Roberts,Gang Wang,Jadwiga A Wedzicha,Rosa Faner,Hans Jacob L Koefoed,Judith M Vonk,Alvar Agusti,Gerard H Koppelman,Erik Melén,Adnan Custovic,
BACKGROUND Lung function during childhood is an important predictor of subsequent health and disease. Understanding patterns of lung function and development of airflow limitation through childhood is necessary to inform lung function trajectories in relation to health and chronic airway disease. We aimed to derive trajectories of airflow limitation from childhood (age 5-8 years) into early adulthood
-
Early childhood developmental concerns following SARS-CoV-2 infection and COVID-19 vaccination during pregnancy: a Scottish population-level retrospective cohort study. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Iain Hardie,Louise Marryat,Aja Murray,Josiah King,Kenneth Okelo,James P Boardman,Michael V Lombardo,Sarah J Stock,Rachael Wood,Bonnie Auyeung
BACKGROUND Understanding the effects of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy can help inform clinical guidance and tackle vaccine hesitancy. We examined relationships between SARS-CoV-2 infection during pregnancy, COVID-19 vaccination during pregnancy, and early child developmental concerns in children aged 13-15 months in Scotland. METHODS We created a large, population-level
-
Children need space and support to talk about their pain. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Tanvi Hirekodi,Rebeccah Slater
-
Ethical and legal considerations in the care of children and young people with high consequence infectious diseases (HCIDs): an approach to decision making. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Elizabeth Whittaker,Ruchi Sinha,Andrew Riordan,Alejandra Alonso,Marieke Emonts,Stephen Owens,Jonathan Cohen,Sarah Mahoney,David Porter,Beatriz Larru,Shelley Segal,Joe Brierley
High consequence infectious diseases (such as Ebola virus or avian influenza) require specialist management with strict isolation to avoid spread to health-care staff and the wider community. These infections present various ethical and legal issues for children and young people. Specific challenges include the impact of isolation on the child and family (potentially without a child's consent), limitations
-
Daniela Ligiero: driving action to end violence against children. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Udani Samarasekera
-
Toxic air: the biggest environmental killer of children in Europe and Central Asia. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Megan Tatum
-
Can lung disease be averted by focusing on early-life inequities? Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Shannon J Simpson,Sanja Stanojevic
-
Urgently expanding access to improved treatment for children with multidrug-resistant tuberculosis. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 Nishesh Tiwari,Jennifer Furin
-
Spotlighting appendicitis in child and adolescent health. Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-03-01 The Lancet Child Adolescent Health
-
Promoting the mental wellbeing of adolescents experiencing poverty alleviation relocation in China Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-02-17 Yan'e Lu, Jing Wang, Jia Jia Liu, Lin Lu
-
Tailoring organ dysfunction criteria for critically ill children with cancer Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-02-12 Roelie M Wösten-van Asperen, Melissa R Hines, Luregn J Schlapbach, Asya Agulnik
-
Weight-loss medications: promoting health and not harm Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-28 Lauren B Hartman, Abigail A Donaldson, Laura M K Prakash, Maya M Kumar
-
Correction to Lancet Child Adolesc Health 2025; 9: 37–46 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22
-
-
Political will to tackle childhood violence in Latin America Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Udani Samarasekera
-
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Anthony J Garcia-Prats MD, Maria Garcia-Cremades PhD, Vivian Cox MD, Tamara Kredo PhD, Rory Dunbar PhD, Prof H Simon Schaaf PhD, Prof James A Seddon PhD, Jennifer Furin MD, Jay Achar MBBS, Kendra Radke PhD, Tina Sachs MSc, Amanzhan Abubakirov MD, Saman Ahmed MPH, Onno W Akkerman PhD, Nadia Abdulkareem Al Ani MSc, Farhana Amanullah MD, Nafees Ahmad PhD, Laura F Anderson PhD, Meseret Asfaw MD, Funeka
There are few data on the treatment of children and adolescents with multidrug-resistant (MDR) or rifampicin-resistant (RR) tuberculosis, especially with more recently available drugs and regimens. We aimed to describe the clinical and treatment characteristics and their associations with treatment outcomes in this susceptible population.
-
International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Laura Botta MSc, Fabio Didonè MSc, Angela Lopez-Cortes MSc, Adela Cañete Nieto PhD, Emmanuel Desandes MD, Lisa L Hjalgrim PhD, Zsuzsanna Jakab MD, Charles A Stiller MSc, Bernward Zeller MD, Gemma Gatta MD, Prof Kathy Pritchard-Jones PhD, BENCHISTA Project Working Group, Joanne Aitken, Leisa O'Neill, Danny Youlden, Monika Hackl, Ruth Ladenstein, Elizabeth Van Eycken, Nancy Van Damme, Beatriz De Camargo
International variation in childhood cancer survival might be explained by differences in stage at diagnosis, among other factors. As part of the BENCHISTA project, we aimed to assess geographical variation in tumour stage at diagnosis through the application, by population-based cancer registries working with clinicians, of the international consensus Toronto Childhood Cancer Stage Guidelines.
-
Correction to Lancet Child Adolesc Health 2025; 9: 10–14 Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22
-
Evaluating care quality and appropriateness when promoting health-care seeking for children – Authors' reply Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Myrthe van den Broek, Mark J D Jordans
-
Evaluating care quality and appropriateness when promoting health-care seeking for children Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Man Lui Chan, Kwok Ying Chan, Anthea Wan Hung Chan
-
Patricia Young: advocating for children in humanitarian crises Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Udani Samarasekera
-
A toolbox for innovative paediatric research Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 The Lancet Child & Adolescent Health
-
Timeliness and value of individual participant data meta-analyses in paediatric tuberculosis research Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Ben J Marais, Mikaela Coleman, Leyla Larsson, Katharina Kranzer
-
Children and young people with mental health concerns admitted to medical wards Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Josephine Holland
-
Harnessing n-of-1 trials for personalised paediatric care in the era of information overload Lancet Child Adolesc. Health (IF 19.9) Pub Date : 2025-01-22 Joyce P Samuel